CCDA1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (made-to-order)
Synonyms
CCDA1 antibody; Os11g0140800 antibody; LOC_Os11g04500 antibody; OsJ_32910Cytochrome c-type biogenesis ccda-like chloroplastic protein 1 antibody; Cytochrome b6f biogenesis protein CCDA1 antibody
Target Names
CCDA1
Uniprot No.

Target Background

Function
This antibody targets a protein likely involved in the transfer of reducing equivalents from the stroma to the thylakoid lumen. It is also required for the biogenesis of the plastid cytochrome b6f complex.
Database Links
Protein Families
DsbD family
Subcellular Location
Plastid, chloroplast thylakoid membrane; Multi-pass membrane protein.

Q&A

What is CCDA1 and what are its functional roles in cellular systems?

CCDA1 (Cytochrome c deficient A1) is an integral membrane protein with six transmembrane regions that plays a critical role in redox pathways. In organisms like Streptococcus gordonii, CCDA1 functions within the methionine sulfoxide reductase (MsrAB) reducing pathway . In this pathway, CCDA1 reduces disulfide bond-containing proteins such as SdbB and Sgo_1177, which in turn reduce MsrAB. This enables the continuous reduction of methionine sulfoxide, protecting cells against oxidative stress .

In plant systems like Oryza sativa (rice), CCDA1 is encoded by the gene LOC4349738 (Q2RAR6) . Plant CCDA1 proteins typically localize to the chloroplast thylakoid membrane and participate in redox reactions essential for photosynthetic electron transport.

The functional domains of CCDA1 include:

DomainFunctionConservation
Transmembrane domainsMembrane anchoringHighly conserved
Thioredoxin-like domainThiol-disulfide exchangeConserved CXXC motif
C-terminal domainInteraction with partner proteinsVariable between species

What are the key considerations for validating CCDA1 antibody specificity?

Antibody validation is critical for ensuring research reproducibility and reliability. When validating CCDA1 antibodies, researchers should consider:

  • Multiple validation approaches: As demonstrated in studies of other antibodies like CC1 (which was found to bind Quaking 7 rather than its intended target APC) , using multiple validation methods is crucial. For CCDA1 antibodies, this should include:

    • Western blotting with appropriate positive and negative controls

    • Immunoprecipitation followed by mass spectrometry

    • Genetic knockout/knockdown validation

    • Immunofluorescence with subcellular localization verification

  • Cross-reactivity testing: Similar to how the CDK1 antibody A17 was found to cross-react with CEP152 , CCDA1 antibodies should be tested against related proteins, particularly other CCDA family members.

  • Validation in multiple experimental systems: As shown in search result , CcdA1 and CcdA2 have similar but distinct functions in redox pathways. Testing antibody specificity across different experimental systems is essential to distinguish between these related proteins .

  • Blocking peptide experiments: These experiments, where the antibody is pre-incubated with the immunizing peptide, can confirm specificity as shown in general antibody validation protocols .

Validation is particularly important given documented cases where antibodies showed unexpected cross-reactivity, compromising research validity and reproducibility .

How should researchers optimize protein extraction protocols for CCDA1 detection?

Given that CCDA1 is a transmembrane protein with six transmembrane regions , optimizing extraction protocols is crucial for successful detection:

  • Membrane protein extraction methods:

    • Use detergent-based approaches with mild detergents like n-dodecylphosphocholine (DPC) at concentrations around 3 mM

    • Consider two-phase extraction systems for improved membrane protein isolation

    • Avoid harsh detergents that may denature the protein's structure

  • Redox state preservation:

    • Include reducing agents (DTT, 2-mercaptoethanol) in extraction buffers to maintain the native redox state

    • Consider alkylation of free thiols with maleimide-PEG2-biotin to prevent post-extraction oxidation

    • Buffer systems containing sodium phosphate (pH 7) have been successfully used with CcdA proteins

  • Subcellular fractionation:

    • For plant samples, chloroplast isolation followed by thylakoid membrane purification improves detection

    • For bacterial samples, careful separation of membrane fractions from cytosolic proteins is essential

  • Sample preparation for immunoblotting:

    • Avoid boiling samples containing membrane proteins like CCDA1

    • Use lower concentrations of SDS (0.1%) and shorter heating times (37°C for 30 minutes)

    • Run samples on gradient gels (4-12%) for better resolution

These optimizations are critical because standard protein extraction protocols often fail to efficiently extract membrane proteins, leading to false negative results.

What are the most effective applications of CCDA1 antibodies in plant research?

CCDA1 antibodies have several key applications in plant research:

  • Studying chloroplast redox regulation: CCDA1 antibodies can be used to investigate thiol-disulfide exchange pathways in chloroplasts, particularly in response to environmental stresses.

  • Developmental biology: Tracking CCDA1 expression during different developmental stages can provide insights into chloroplast maturation and photosynthetic apparatus assembly.

  • Protein-protein interaction studies:

    • Immunoprecipitation experiments can identify CCDA1-interacting proteins

    • Similar to studies with CcdA1 in bacterial systems , plant CCDA1 antibodies can help delineate redox partners

  • Stress response analysis: Examining CCDA1 expression and modification under various stress conditions (drought, high light, temperature extremes) can reveal adaptive mechanisms.

  • Comparative studies across species: CCDA1 antibodies that recognize conserved epitopes can be used to examine evolutionary conservation of redox pathways across plant species.

The most effective applications depend on careful validation, as detailed in question 2, and appropriate experimental design that considers the membrane localization of CCDA1.

How can researchers troubleshoot nonspecific binding when using CCDA1 antibodies?

Nonspecific binding is a common challenge with antibodies targeting membrane proteins like CCDA1. Effective troubleshooting approaches include:

  • Optimization of blocking conditions:

    • Test different blocking agents (BSA, milk, commercial blockers)

    • Increase blocking time and concentration

    • Add 0.1-0.3% Triton X-100 or Tween-20 to reduce hydrophobic interactions

  • Antibody dilution optimization:

    • Perform titration experiments to determine optimal antibody concentration

    • For CCDA1 antibodies, starting dilutions of 1:500-1:2000 for Western blot and 1:200-1:1000 for immunofluorescence have been reported effective for similar membrane proteins

  • Additional washing steps:

    • Increase wash buffer stringency (higher salt concentration, addition of mild detergents)

    • Extend washing times between antibody incubations

  • Cross-adsorption of antibodies:

    • Pre-incubate antibodies with lysates from tissues not expressing the target

    • This approach can reduce binding to cross-reactive proteins, similar to strategies used for other antibodies

  • Alternative detection methods:

    • Try different secondary antibodies or detection systems

    • For particularly challenging samples, consider switching from chromogenic to fluorescent or chemiluminescent detection

A systematic approach to troubleshooting is essential, changing only one parameter at a time and documenting all modifications to protocols.

What are the differences between polyclonal and monoclonal antibodies for CCDA1 detection?

When choosing between polyclonal and monoclonal antibodies for CCDA1 research, consider these differences:

CharacteristicPolyclonal CCDA1 AntibodiesMonoclonal CCDA1 Antibodies
Epitope recognitionRecognize multiple epitopes Target single epitope
SensitivityHigher sensitivity due to multiple epitope bindingPotentially lower sensitivity
SpecificityMay have higher cross-reactivityHigher specificity for single epitope
Batch-to-batch variationSignificant variation between batchesMinimal variation between batches
Production methodGenerated in rabbits or other animals against CCDA1 protein Developed from single B-cell clone
ApplicationsBetter for detection of native proteins, immunoprecipitationIdeal for distinguishing closely related proteins
Resilience to target modificationMore resistant to changes in antigen (denaturation, fixation)More sensitive to epitope modifications
Cost and availabilityGenerally less expensive and more readily availableMore expensive and may be limited for specialized targets

For CCDA1 research, polyclonal antibodies have been successfully used in applications like Western blotting and ELISA . These antibodies are typically raised against recombinant CCDA1 protein and purified using affinity chromatography with the immunizing antigen .

The choice between polyclonal and monoclonal antibodies should be guided by the specific research question and experimental approach.

How do oxidation-reduction states affect epitope recognition by CCDA1 antibodies?

Since CCDA1 functions in redox pathways and contains critical cysteine residues , the oxidation-reduction state significantly impacts epitope recognition:

  • Conformational changes: CCDA1 undergoes significant conformational changes between oxidized and reduced states, which can expose or mask epitopes:

    • Reduced CCDA1 typically has exposed thiol groups in the active site

    • Oxidized CCDA1 forms disulfide bonds that alter protein conformation

  • Sample preparation considerations:

    • Inclusion of reducing agents (DTT, 2-mercaptoethanol) in sample buffers can expose epitopes hidden in the oxidized state

    • For studying the native redox state, samples should be alkylated with maleimide-PEG2-biotin or similar reagents to preserve the thiol status

  • Antibody selection strategy:

    • Antibodies raised against peptides from non-redox-active regions will be less affected

    • Antibodies targeting the CXXC motif may show redox-dependent binding

  • Experimental validation:

    • Control experiments with fully reduced (DTT-treated) and fully oxidized (oxidized glutathione-treated) samples are recommended

    • Differential detection between these states can be exploited to study CCDA1 redox cycling in vivo

Understanding the impact of redox state on epitope recognition is critical for correctly interpreting experimental results, particularly in studies examining CCDA1 function under oxidative stress conditions.

What advanced techniques can be used to study CCDA1 protein-protein interactions?

For advanced study of CCDA1 protein-protein interactions, researchers can employ:

  • Proximity-based labeling techniques:

    • BioID or TurboID fusions with CCDA1 to identify proximal proteins in the native membrane environment

    • APEX2-based proximity labeling for temporal control of interaction mapping

  • Cross-linking mass spectrometry (XL-MS):

    • Application of membrane-permeable crosslinkers followed by immunoprecipitation with CCDA1 antibodies

    • This approach can capture transient interactions in the redox pathway, similar to studies in bacterial systems

  • Split reporter assays:

    • Split-GFP, split-luciferase, or split-ubiquitin systems adapted for membrane proteins

    • Particularly useful for confirming direct interactions identified through other methods

  • FRET/FLIM-based approaches:

    • For studying dynamic interactions between CCDA1 and partner proteins

    • Requires fluorophore-conjugated antibodies or expression of fluorescent protein fusions

  • Native co-immunoprecipitation with specialized detergents:

    • Use of digitonin, DDM, or other mild detergents that preserve membrane protein complexes

    • Similar to approaches used in studies of membrane protein complexes in redox systems

These advanced techniques can reveal the complete interactome of CCDA1, providing insights into its role in redox regulation and other cellular processes beyond what traditional co-immunoprecipitation approaches might reveal.

How can CCDA1 antibodies be used to study evolutionary conservation across species?

CCDA1 antibodies can be powerful tools for evolutionary studies when used methodically:

  • Epitope selection for cross-species reactivity:

    • Target highly conserved regions of CCDA1 for antibody generation

    • Alignment analysis of CCDA1 sequences across species can identify conserved epitopes

    • The transmembrane domains and functional CXXC motifs are typically well-conserved and make good targets

  • Validation across species:

    • Systematic testing against protein extracts from diverse species

    • Western blot analysis with recombinant CCDA1 proteins from different species as controls

    • Similar to validation approaches used for other antibodies , specificity must be confirmed in each species

  • Comparative expression analysis:

    • Examination of CCDA1 expression patterns across developmental stages in different species

    • Quantitative analysis of expression levels in homologous tissues

  • Functional conservation studies:

    • Immunoprecipitation of CCDA1 from different species followed by activity assays

    • Analysis of interaction partners to determine conservation of redox pathways

  • Subcellular localization comparison:

    • Immunolocalization studies across species to determine if CCDA1 targeting is conserved

    • Combined with organelle markers to confirm precise localization

Such evolutionary studies can reveal important insights into the conservation of redox regulation mechanisms across diverse plant lineages and potentially identify species-specific adaptations in CCDA1 function.

What methodological approaches are recommended for studying CCDA1 post-translational modifications?

Studying post-translational modifications (PTMs) of CCDA1 requires specialized approaches:

  • Redox-state specific detection:

    • Differential alkylation of thiols using iodoacetamide/N-ethylmaleimide followed by detection with CCDA1 antibodies

    • Redox Western blotting with non-reducing/reducing gel comparisons

    • Similar approaches have been used to study the oxidation state of cysteine residues in redox proteins

  • Phosphorylation analysis:

    • Immunoprecipitation with CCDA1 antibodies followed by phospho-specific antibody detection

    • Phos-tag gel electrophoresis for mobility shift detection of phosphorylated CCDA1

    • Mass spectrometry analysis of immunoprecipitated CCDA1 to identify specific phosphorylation sites

  • Other PTM detection strategies:

    • Site-specific antibodies against predicted PTM sites on CCDA1

    • Enrichment of modified CCDA1 using PTM-specific capture reagents prior to antibody detection

    • Mass spectrometry analysis following CCDA1 immunoprecipitation

  • Functional impact assessment:

    • Correlation of PTM status with CCDA1 activity in redox transfer assays

    • Mutagenesis of PTM sites followed by functional complementation studies

    • Temporal analysis of PTM dynamics during stress responses or developmental transitions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.